NCT00357461View on ClinicalTrials.gov

Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2006

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

gp100:209-217(210M) peptide vaccine

BIOLOGICAL

gp100:280-288(288V) peptide vaccine

BIOLOGICAL

incomplete Freund's adjuvant

BIOLOGICAL

ipilimumab

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Bristol-Myers Squibb

INDUSTRY